The impact of language errors in clinical trials can be significant, leading to confusion for the participants and researchers. These frustrating events can lead to dropouts, delays in execution timelines, and even affect the validity of the ultimate trial results. Because of this, regulatory agencies now require that global clinical trials are accurate, consistent, and culturally appropriate in each of the local countries they are administered.
Investing in high-quality transcreation services can be a major differentiator for a successful clinical trial, by ensuring regulatory compliance and improved patient outcomes.
